Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Aug 2;91(16):7593–7597. doi: 10.1073/pnas.91.16.7593

Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein.

G S Baldwin 1
PMCID: PMC44448  PMID: 8052625

Abstract

Inhibition of colon carcinoma cell growth by the nonselective gastrin/cholecystokinin (CCK) receptor antagonists proglumide and benzotript provided evidence that gastrin functions as an autocrine growth factor. However, the molecular properties of the receptor mediating the antagonist effects have not been identified. A 78-kDa gastrin-binding protein (GBP), the sequence of which is related to the family of enzymes possessing enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase activities, has been previously purified from porcine gastric mucosal membranes. I now report that covalent cross-linking of 125I-labeled [Nle15]gastrin2,17 to the 78-kDa GBP is inhibited by crotonyl-CoA and by acetoacetyl-CoA. Gastrin, CCK, and their analogues also inhibit cross-linking, and the spectrum of analogue affinities correlates better with the values previously reported for binding to the gastrin/CCK-C receptor than with the values reported for binding to either the CCK-A or the gastrin/CCK-B receptor. Cross-linking is also inhibited by proglumide and benzotript, but no inhibition is seen with either the CCK-A receptor-selective antagonist L364,718 or the gastrin/CCK-B receptor-selective antagonist L365,260. The affinities of antagonists for the GBP correlate well with their affinities for the gastrin/CCK-C receptor and with their potencies for inhibition of colon carcinoma cell growth. I conclude that the 78-kDa gastrin-binding protein is (i) a member of the hydratase/dehydrogenase family of fatty acid oxidation enzymes, (ii) the gastrin/CCK-C receptor, and (iii) the target for the antiproliferative action of two gastrin/CCK receptor antagonists.

Full text

PDF
7597

Images in this article

7594Image
on p.7594
7595Image
on p.7595

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin G. S., Casey A., Mantamadiotis T., McBride K., Sizeland A. M., Thumwood C. M. PCR cloning and sequence of gastrin mRNA from carcinoma cell lines. Biochem Biophys Res Commun. 1990 Jul 31;170(2):691–697. doi: 10.1016/0006-291x(90)92146-q. [DOI] [PubMed] [Google Scholar]
  2. Baldwin G. S., Casey A., Weinstock J. Partial structure of the gene encoding the 78 kDa gastrin binding protein excludes a close relationship with the peroxisomal trifunctional enzyme. Biochem Biophys Res Commun. 1993 Jun 15;193(2):560–564. doi: 10.1006/bbrc.1993.1660. [DOI] [PubMed] [Google Scholar]
  3. Baldwin G. S., Chandler R., Grego B., Rubira M. R., Seet K. L., Weinstock J. Isolation and partial amino acid sequence of a 78 kDa porcine gastrin-binding protein. Int J Biochem. 1994 Apr;26(4):529–538. doi: 10.1016/0020-711x(94)90010-8. [DOI] [PubMed] [Google Scholar]
  4. Baldwin G. S., Chandler R., Scanlon D. B., Weinstock J. Identification of a gastrin binding protein in porcine gastric mucosal membranes by covalent cross-linking with iodinated gastrin. J Biol Chem. 1986 Sep 15;261(26):12252–12257. [PubMed] [Google Scholar]
  5. Baldwin G. S. Comparison of sequences of the 78 kDa gastrin-binding protein and some enzymes involved in fatty acid oxidation. Comp Biochem Physiol B. 1993 Jan;104(1):55–61. doi: 10.1016/0305-0491(93)90337-5. [DOI] [PubMed] [Google Scholar]
  6. Baldwin G. S., Zhang Q. X. Measurement of gastrin and transforming growth factor alpha messenger RNA levels in colonic carcinoma cell lines by quantitative polymerase chain reaction. Cancer Res. 1992 Apr 15;52(8):2261–2267. [PubMed] [Google Scholar]
  7. Beauchamp R. D., Townsend C. M., Jr, Singh P., Glass E. J., Thompson J. C. Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice. Ann Surg. 1985 Sep;202(3):303–309. doi: 10.1097/00000658-198509000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Blackmore M., Hirst B. H. Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin. Br J Cancer. 1992 Jul;66(1):32–38. doi: 10.1038/bjc.1992.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chang R. S., Lotti V. J., Chen T. B., Kunkel K. A. Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors. Mol Pharmacol. 1986 Sep;30(3):212–217. [PubMed] [Google Scholar]
  10. Chang R. S., Lotti V. J., Monaghan R. L., Birnbaum J., Stapley E. O., Goetz M. A., Albers-Schönberg G., Patchett A. A., Liesch J. M., Hensens O. D. A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science. 1985 Oct 11;230(4722):177–179. doi: 10.1126/science.2994227. [DOI] [PubMed] [Google Scholar]
  11. Finley G. G., Koski R. A., Melhem M. F., Pipas J. M., Meisler A. I. Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma. Cancer Res. 1993 Jun 15;53(12):2919–2926. [PubMed] [Google Scholar]
  12. Frucht H., Gazdar A. F., Park J. A., Oie H., Jensen R. T. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res. 1992 Mar 1;52(5):1114–1122. [PubMed] [Google Scholar]
  13. Furuta S., Miyazawa S., Osumi T., Hashimoto T., Ui N. Properties of mitochondria and peroxisomal enoyl-CoA hydratases from rat liver. J Biochem. 1980 Oct;88(4):1059–1070. doi: 10.1093/oxfordjournals.jbchem.a133057. [DOI] [PubMed] [Google Scholar]
  14. Guo Y. S., Baijal M., Jin G. F., Thompson J. C., Townsend C. M., Jr, Singh P. Growth-promoting effects of gastrin on mouse colon cancer cells in vitro: absence of autocrine effects. In Vitro Cell Dev Biol. 1990 Sep;26(9):871–877. doi: 10.1007/BF02624612. [DOI] [PubMed] [Google Scholar]
  15. Hoosein N. M., Kiener P. A., Curry R. C., Rovati L. C., McGilbra D. K., Brattain M. G. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res. 1988 Dec 15;48(24 Pt 1):7179–7183. [PubMed] [Google Scholar]
  16. Ito M., Matsui T., Taniguchi T., Tsukamoto T., Murayama T., Arima N., Nakata H., Chiba T., Chihara K. Functional characterization of a human brain cholecystokinin-B receptor. A trophic effect of cholecystokinin and gastrin. J Biol Chem. 1993 Aug 25;268(24):18300–18305. [PubMed] [Google Scholar]
  17. Kochman M. L., DelValle J., Dickinson C. J., Boland C. R. Post-translational processing of gastrin in neoplastic human colonic tissues. Biochem Biophys Res Commun. 1992 Dec 15;189(2):1165–1169. doi: 10.1016/0006-291x(92)92326-s. [DOI] [PubMed] [Google Scholar]
  18. Kusyk C. J., McNiel N. O., Johnson L. R. Stimulation of growth of a colon cancer cell line by gastrin. Am J Physiol. 1986 Nov;251(5 Pt 1):G597–G601. doi: 10.1152/ajpgi.1986.251.5.G597. [DOI] [PubMed] [Google Scholar]
  19. Lee Y. M., Beinborn M., McBride E. W., Lu M., Kolakowski L. F., Jr, Kopin A. S. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem. 1993 Apr 15;268(11):8164–8169. [PubMed] [Google Scholar]
  20. Mantamadiotis T., Sobieszczuk P., Weinstock J., Baldwin G. S. Nucleotide sequence encoding a novel member of the hydratase/dehydrogenase family. Biochim Biophys Acta. 1993 Oct 13;1170(2):211–215. doi: 10.1016/0005-2760(93)90073-i. [DOI] [PubMed] [Google Scholar]
  21. McPherson G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed. 1983 Aug-Oct;17(1-2):107–113. doi: 10.1016/0010-468x(83)90031-4. [DOI] [PubMed] [Google Scholar]
  22. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  23. Nemeth J., Taylor B., Pauwels S., Varro A., Dockray G. J. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut. 1993 Jan;34(1):90–95. doi: 10.1136/gut.34.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pisegna J. R., de Weerth A., Huppi K., Wank S. A. Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization. Biochem Biophys Res Commun. 1992 Nov 30;189(1):296–303. doi: 10.1016/0006-291x(92)91557-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sethi T., Herget T., Wu S. V., Walsh J. H., Rozengurt E. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Cancer Res. 1993 Nov 1;53(21):5208–5213. [PubMed] [Google Scholar]
  26. Singh P., Le S., Beauchamp R. D., Townsend C. M., Jr, Thompson J. C. Inhibition of pentagastrin-stimulated up-regulation of gastrin receptors and growth of mouse colon tumor in vivo by proglumide, a gastrin receptor antagonist. Cancer Res. 1987 Oct 1;47(19):5000–5004. [PubMed] [Google Scholar]
  27. Singh P., Rae-Venter B., Townsend C. M., Jr, Khalil T., Thompson J. C. Gastrin receptors in normal and malignant gastrointestinal mucosa: age-associated changes. Am J Physiol. 1985 Dec;249(6 Pt 1):G761–G769. doi: 10.1152/ajpgi.1985.249.6.G761. [DOI] [PubMed] [Google Scholar]
  28. Smith J. P., Solomon T. E. Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology. 1988 Dec;95(6):1541–1548. doi: 10.1016/s0016-5085(88)80075-1. [DOI] [PubMed] [Google Scholar]
  29. Thumwood C. M., Hong J., Baldwin G. S. Inhibition of cell proliferation by the cholecystokinin antagonist L-364,718. Exp Cell Res. 1991 Jan;192(1):189–192. doi: 10.1016/0014-4827(91)90174-s. [DOI] [PubMed] [Google Scholar]
  30. Uchida Y., Izai K., Orii T., Hashimoto T. Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem. 1992 Jan 15;267(2):1034–1041. [PubMed] [Google Scholar]
  31. Ulrich C. D., Ferber I., Holicky E., Hadac E., Buell G., Miller L. J. Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor. Biochem Biophys Res Commun. 1993 May 28;193(1):204–211. doi: 10.1006/bbrc.1993.1610. [DOI] [PubMed] [Google Scholar]
  32. Upp J. R., Jr, Singh P., Townsend C. M., Jr, Thompson J. C. Clinical significance of gastrin receptors in human colon cancers. Cancer Res. 1989 Jan 15;49(2):488–492. [PubMed] [Google Scholar]
  33. Van Solinge W. W., Nielsen F. C., Friis-Hansen L., Falkmer U. G., Rehfeld J. F. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology. 1993 Apr;104(4):1099–1107. doi: 10.1016/0016-5085(93)90279-l. [DOI] [PubMed] [Google Scholar]
  34. Watson S. A., Durrant L. G., Morris D. L. Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro. Br J Surg. 1988 Apr;75(4):342–345. doi: 10.1002/bjs.1800750416. [DOI] [PubMed] [Google Scholar]
  35. Watson S., Durrant L., Morris D. Gastrin: growth enhancing effects on human gastric and colonic tumour cells. Br J Cancer. 1989 Apr;59(4):554–558. doi: 10.1038/bjc.1989.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Weinstock J., Baldwin G. S. Binding of gastrin(17) to human gastric carcinoma cell lines. Cancer Res. 1988 Feb 15;48(4):932–937. [PubMed] [Google Scholar]
  37. de Weerth A., Pisegna J. R., Huppi K., Wank S. A. Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem Biophys Res Commun. 1993 Jul 30;194(2):811–818. doi: 10.1006/bbrc.1993.1894. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES